Related Experiment Videos
Summary
Government policies impact pharmaceutical innovation. Stricter regulations and shorter patents reduce new drug development incentives, increasing costs and decreasing new therapies. Policy reforms are explored.
Area of Science:
- Pharmaceutical Sciences
- Health Policy
- Economics
Background:
- New drug introductions historically drive medical progress and cost-effective therapies.
- Recent public policy trends include stringent regulatory controls, shorter patent terms, and promotion of generic drugs.
- These policies negatively affect firm incentives and capabilities for new drug research and development.
Purpose of the Study:
- To analyze the effects of government regulatory policies on pharmaceutical innovation.
- To examine public policy proposals aimed at stimulating drug innovation, such as patent restoration and regulatory reforms.
Main Methods:
- The study considers the effects of government regulatory policies on the pharmaceutical innovation process from multiple perspectives.
- It evaluates current policy proposals designed to enhance drug innovation.
Main Results:
- Rising research and development costs.
- Declining annual new drug introductions.
- Fewer independent sources of drug development.
Conclusions:
- Current public policy, while aiming for cost-effectiveness, may inadvertently stifle pharmaceutical innovation.
- Policy reforms, including patent restoration and regulatory adjustments, are crucial for sustaining the development of new therapies.